ATI RN
ATI RN Mental Health 2023 Exam 2 Questions
Extract:
Question 1 of 5
A nurse is caring for a client who is seeking help to quit smoking. Which of the following prescriptions should the nurse expect the provider to prescribe?
Correct Answer: C
Rationale: The correct answer is C: Varenicline. This is because Varenicline is a medication specifically indicated for smoking cessation. It works by reducing the pleasurable effects of nicotine and decreasing cravings. Naltrexone (
A) is used for alcohol and opioid dependence, not smoking cessation. Donepezil (
B) is used to treat Alzheimer's disease. Disulfiram (
D) is used to deter alcohol consumption by causing unpleasant effects when alcohol is ingested. Hence, the nurse should expect the provider to prescribe Varenicline to help the client quit smoking effectively.
Question 2 of 5
A nurse is planning care for a client who has complicated grieving following the death of her child. Which of the following interventions should the nurse identify as the priority?
Correct Answer: A
Rationale: The correct answer is A: Identify the client's current stage of grief. This is the priority because understanding the client's current stage of grief allows the nurse to tailor interventions accordingly. By assessing the client's stage, the nurse can provide targeted support and interventions to help the client process and cope with their grief effectively.
Choice B is incorrect because while informing the client about expected feelings is important, it is not the priority over assessing the current stage of grief.
Choice C is incorrect as physical activities may not be suitable or helpful depending on the client's stage of grief.
Choice D is also incorrect as discussing the use of a spiritual grief counselor should come after assessing the client's current needs and preferences.
Question 3 of 5
A nurse is providing teaching to a client who is newly diagnosed with Alzheimer's disease. Which of the following treatment options should the nurse include in the teaching?
Correct Answer: D
Rationale: The correct answer is D: Delaying cognitive impairment with NMDA receptor agonist medications. NMDA receptor agonists have been shown to slow down the progression of cognitive decline in Alzheimer's disease by modulating glutamate transmission. This treatment option can help improve cognitive function and quality of life for the client.
A: Transcranial magnetic stimulation may help with certain psychiatric conditions but is not a standard treatment for Alzheimer's disease.
B: Barbiturate medications are not recommended for controlling anxiety in Alzheimer's disease due to their sedative effects and potential for cognitive impairment.
C: Hospice care services are typically considered in the advanced stages of Alzheimer's when curative treatments are no longer effective, not at the time of diagnosis.
In summary, option D is the most appropriate choice as it directly addresses the management of Alzheimer's disease symptoms and progression.
Question 4 of 5
A nurse is assessing a client who has been receiving electroconvulsive therapy. Which of the following findings indicates the treatment is effective?
Correct Answer: D
Rationale: The correct answer is D: Improvement in manifestations of depression. Electroconvulsive therapy is primarily used to treat severe depression. Improvement in depressive symptoms indicates the treatment is effective. Decreased fear of heights (
A) is not a typical outcome of ECT. ECT is not used to treat seizures (
B). ECT may not directly target symptoms of borderline personality disorder (
C).
Question 5 of 5
A nurse is preparing to administer haloperidol 7 mg IM to a client who is severely agitated. Available is haloperidol injection 5 mg/mL. How many mL should the nurse administer? (Round the answer to the nearest tenth. Use a leading zero if it applies. Do not use a trailing zero.)
Correct Answer: 1.4
Rationale: The correct answer is 1.4 mL.
To calculate this, you divide the desired dose by the concentration of the drug. In this case, 7 mg ÷ 5 mg/mL = 1.4 mL. This ensures the client receives the correct dosage.
Choice A (2.5 mL) is incorrect as it would result in administering more than the prescribed dose.
Choice B (0.5 mL) is incorrect as it would not provide the full 7 mg dose needed for the client's condition.
Choice C (3 mL) is incorrect as it would exceed the prescribed dosage, potentially leading to adverse effects.
Choice D, E, F, and G are not valid options as they are not within a reasonable range based on the calculation.